TELODEN

Class [005]
Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system and peripheral nervous system comprising pyrimidines, nucleic acids, RNA, DNA and glucosamine in tablet, capsule, powder and liquid solution form; Veterinary pharmaceutical preparations for the treatment of the diseases and disorders of the central nervous system and peripheral nervous system comprising pyrimidines, nucleic acids, RNA, DNA and glucosamine in tablet, capsule, powder and liquid solution form; Pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the central nervous system, namely stimulants of the central nervous system; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; Pharmaceutical preparations for treating peripheral nervous system disorders and diseases; pharmaceutical preparations for the peripheral nervous system, namely, stimulants of the peripheral nervous system; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, sensorimotor neuropathies and plexopathies.